KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastoma
Alexandra D’Oto(St. Jude Children's Research Hospital), Jun J. Yang(St. Jude Children's Research Hospital)
Cited by 3
Related Papers
Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse
|Nature Genetics|2013|308
Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia
|Nature Genetics|2013|293
Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study
|The Lancet Oncology|2015|210
Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma
|Nature Communications|2023|41